Search for: "Glaxo Group Limited"
Results 21 - 40
of 49
Sort by Relevance
|
Sort by Date
13 May 2011, 2:35 pm
Cutillo previously pleaded guilty to charges related to his role in the Galleon Group insider trading scheme.Federal Judge Acquits Ex-Glaxo Lawyer Before Defense Even Starts [NPR] Ex-Ropes & Gray Associate Disbarred after Rajaratnam Verdict [Am Law Daily]Earlier: Ropes & Gray Sued for Age and Sex Discrimination By Former Partner Lawyers of the Day: Arthur Cutillo, Michael Kimelman, and Jason GoldfarbJOHN H. [read post]
15 Feb 2011, 4:06 am
Moreover, the industry has agreed upon and abides by the PhRMA Code to regulate the marketing of medicine to healthcare professionals-just as any consumer-products maker might develop rules to limit the express warranties its sales force might offer to a customer. [read post]
3 Feb 2011, 9:34 am
In reasons issued late last year, the Federal Court of Appeal has upheld a decision to expunge a trademark registration obtained by Glaxo Group Limited (“Glaxo”) for two-tones of the colour purple as applied to the visible surface of an asthma inhaler. [read post]
27 Oct 2010, 8:30 am
For example, in Glaxo Inc. v. [read post]
21 Sep 2010, 7:47 pm
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
11 Aug 2010, 6:14 am
” Glaxo Group, 153 F.3d at 1373. [read post]
5 Aug 2010, 11:06 pm
Cir. 2003), and Glaxo Group Ltd. v. [read post]
8 Apr 2010, 5:21 pm
Glaxo had transferred ownership of the patents-in-suit to ICOS. [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
13 Nov 2009, 11:52 am
USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
19 Oct 2009, 5:53 pm
It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group… [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
8 Oct 2009, 1:56 pm
PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
13 Sep 2009, 1:02 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
13 Sep 2009, 12:55 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
5 May 2009, 5:57 am
The Supreme Court ruling "significantly limited preemption. [read post]
21 Mar 2009, 6:07 am
Cir. 2009, 08-1352) Triantafyllos Tafas, SmithKline Beecham Corporation, and Glaxo Group Limited (collectively “Appellees”) originally filed suit against the USPTO in relation to Final Rules published by the USPTO that placed [...] [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on biologics; draws… [read post]
3 Oct 2008, 7:18 pm
., SmithKline Beecham plc, and Glaxo Group Ltd. [read post]
19 Sep 2008, 6:00 pm
: (Techdirt), (Techdirt), Pharma & Biotech Pharma & Biotech - General Biotech patent law: eleven key pending cases and future developments to watch: (Hal Wegner), (PatentDocs) Study by The Innovation Group highlights damaging intellectual property has been to biotech: (Techdirt), Drug regulatory agencies collaborate on counterfeits, new medical products: (Intellectual Property Watch), Canada: Health Canada releases summary report on industry consultations… [read post]
